PILA PHARMA AB
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
PILA | ST
Overview
Corporate Details
- ISIN(s):
- SE0015988274
- LEI:
- 6488Z7WG18Q0ZN0V0262
- Country:
- Sweden
- Address:
- Norra Vallgatan 72, 211 22 Malmö
- Website:
- https://pilapharma.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
PILA PHARMA AB is a clinical-stage biopharmaceutical company focused on developing a potential first-in-class oral treatment for metabolic diseases, primarily type 2 diabetes and obesity. The company's lead candidate, XEN-D0501, is a TRPV1 antagonist, representing a novel therapeutic approach with a different mechanism of action compared to mainstream treatments. The company's strategy emphasizes the development of a convenient oral tablet to address the large global patient population. PILA PHARMA is actively advancing its clinical program, with a recent strategic focus on dedicated obesity studies aimed at generating a comprehensive data package to facilitate future partnerships.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PILA PHARMA AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PILA PHARMA AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
